Answers are grounded in this paper and cite their sources.
The authors present an analysis of the choice of sample sizes for demonstrating cost-effectiveness of a new treatment or procedure, when data on both cost and efficacy will be collected in a clinical trial. The Bayesian approach to statistics is employed, as well as a novel Bayesian criterion that provides insight into the sample size problem and offers a very flexible formulation.
No takes yet. Share an insight, caveat, or question.
O’Hagan et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: